Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
- PMID: 14615711
- DOI: 10.1067/s0022-3476(03)00510-9
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
Abstract
Objectives: To provide current estimates of the incidence, associated risk factors, and costs of severe respiratory syncytial virus (RSV) infections among infants in the United States, defined as emergency department (ED) visits, hospitalization, and death.
Study design: Retrospective analysis of National Hospital Ambulatory Medical Care Survey data 1997 to 2000; National Hospital Discharge Survey data 1997 to 2000; Perinatal Mortality Linked Files 1998 to 1999. The Hospital Cost Utilization Inpatient Sample data 1997 to 2000 were used to estimate hospitalization costs, and the 2001 Medicare fee schedule was used to estimate ED visit costs. Census data were used for population estimates. Between 1997 and 2000, there were 718,008 ED visits by infants with lower respiratory infection diagnoses during the RSV season (22.8/1000), and 29% were admitted. Costs of ED visits were approximately 202 million US dollars. RSV bronchiolitis was the leading cause of infant hospitalization annually. Total hospital charges for RSV-coded primary diagnoses during the 4 years were more than 2.6 billion US dollars. An estimated 390 RSV-associated postneonatal deaths occurred in 1999. Low birth weight and prematurity significantly increased RSV-associated mortality rates.
Conclusions: RSV is a major cause of infant morbidity and mortality. Severe RSV is highest among infants of black mothers and Medicaid-insured infants. Prematurity and low birth weight significantly increase RSV mortality rates.
Similar articles
-
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.J Infect Dis. 2022 Aug 15;226(Suppl 2):S184-S194. doi: 10.1093/infdis/jiac155. J Infect Dis. 2022. PMID: 35968879 Free PMC article.
-
Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.J Med Econ. 2020 Feb;23(2):139-147. doi: 10.1080/13696998.2019.1658592. Epub 2019 Sep 4. J Med Econ. 2020. PMID: 31432723
-
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4. J Perinatol. 2016. PMID: 27490190 Free PMC article.
-
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416. J Glob Health. 2015. PMID: 26682048 Free PMC article. Review.
-
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.J Infect Dis. 1999 Jan;179(1):25-30. doi: 10.1086/314567. J Infect Dis. 1999. PMID: 9841818 Review.
Cited by
-
Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Vaccines (Basel). 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500. Vaccines (Basel). 2024. PMID: 38793751 Free PMC article. Review.
-
Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis.Infect Dis Rep. 2024 Mar 29;16(2):317-355. doi: 10.3390/idr16020026. Infect Dis Rep. 2024. PMID: 38667752 Free PMC article. Review.
-
Healthcare Utilization Among Infants Covered by Medicaid and Newly Diagnosed With Respiratory Syncytial Virus.Open Forum Infect Dis. 2024 Mar 21;11(4):ofae174. doi: 10.1093/ofid/ofae174. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38595954 Free PMC article.
-
Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis.Pediatr Res. 2024 May;95(6):1441-1447. doi: 10.1038/s41390-023-02953-z. Epub 2023 Dec 8. Pediatr Res. 2024. PMID: 38066246 Free PMC article.
-
Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29-34 wGA) infants without outpatient palivizumab administration.Hum Vaccin Immunother. 2023 Aug;19(2):2252289. doi: 10.1080/21645515.2023.2252289. Epub 2023 Oct 12. Hum Vaccin Immunother. 2023. PMID: 37828711 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical